NQVAX | VEVYX | NQVAX / VEVYX | |
Total Expense Ratio | 1.16 | 0.66 | 176% |
Annual Report Gross Expense Ratio | 1.17 | 0.66 | 177% |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 10.597 | 3.234 | 328% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 641M | 17.4B | 4% |
Annual Yield % from dividends | 1.16 | 1.06 | 110% |
Returns for 1 year | 16.01 | -6.13 | -261% |
Returns for 3 years | 60.01 | 7.22 | 832% |
Returns for 5 years | 125.94 | 38.20 | 330% |
Returns for 10 years | 178.43 | 56.38 | 316% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LQIG | 96.69 | 0.65 | +0.68% |
SPDR MarketAxess Inv Grd 400 Corp Bd ETF | |||
DNP | 9.85 | 0.04 | +0.41% |
DNP Select Income Fund | |||
FLCA | 44.09 | -0.04 | -0.08% |
Franklin FTSE Canada ETF | |||
SMCO | 26.77 | -0.03 | -0.10% |
Hilton Small-MidCap Opportunity ETF | |||
SPIN | 30.73 | -0.18 | -0.59% |
SPDR SSGA US Equity Premium Income ETF |